galiximab galiximab galiximab is a monoclonal antibody designed for the treatment of b-cell lymphoma. as of september 2009, it is undergoing phase iii clinical trials. the drug is a chimeric antibody from macaca irus and homo sapiens. galiximabmonoclonal antibodytypewhole antibodysourcechimeric (primate/human)targetcd80clinical dataatc codenoneidentifierscas number357613-77-5 nchemspidernoneuniis9ox9692zbkeggd04295 y ny (what is this?) (verify)